Apokyn

Apokyn is a brand name of apomorphine, approved by the FDA in the following formulation(s):

APOKYN (apomorphine hydrochloride - injectable; subcutaneous)

• 
  Manufacturer: US WORLDMEDS
  
  Approval date: April 20, 2004
  
  Strength(s): 30MG/3ML (10MG/ML) ^[RLD]

Has a generic version of Apokyn been approved?

No. There is currently no therapeutically equivalent version of Apokyn available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Apokyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Apokyn.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • April 20, 2011 - ORPHAN DRUG EXCLUSIVITY
  
  

See also...

• Apokyn Consumer Information (Drugs.com)
• Apokyn Consumer Information (Wolters Kluwer)
• Apokyn Consumer Information (Cerner Multum)
• Apokyn Advanced Consumer Information (Micromedex)
• Apokyn AHFS DI Monographs (ASHP)
• Apomorphine Consumer Information (Wolters Kluwer)
• Apomorphine Consumer Information (Cerner Multum)
• Apomorphine Subcutaneous Advanced Consumer Information (Micromedex)
• Apomorphine Hydrochloride AHFS DI Monographs (ASHP)